Prostaglandins, the fetal membranes and the cervix

Frontiers of Hormone Research

Volumn 27, Issue , 2001, Pages 147-164

  Bennett, Phillip ^a,b   Allport, Victoria ^a   London, Jenifer ^a   Elliott, Catherine ^a  

^a QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PROGESTERONE; PROSTAGLANDIN;

ANIMAL; EMBRYO MEMBRANE; FEMALE; HUMAN; LABOR; PHYSIOLOGY; PREGNANCY; REVIEW; UTERINE CERVIX;

ANIMALS; CERVIX UTERI; EXTRAEMBRYONIC MEMBRANES; FEMALE; HUMANS; INTERLEUKIN-8; LABOR, OBSTETRIC; NF-KAPPA B; PREGNANCY; PROGESTERONE; PROSTAGLANDINS;

EID: 0035235526     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061024     Document Type: Article

References (70)

1. Carsten ME: Calcium accumulation by human uterine microsomal preparations: Effects of progesterone and oxytocin. Am J Obstet Gynecol 1979;133:598-601.
2. Garfield RE, Merrett D, Grover AK: Gap junction formation and regulation in myometrium. Am J Physiol 1980;239:C217-C228.
3. Fuchs AR, Periyasamy S, Soloff MS: Systemic and local regulation of oxytocin receptors in the rat uterus, and their functional significance. Can J Biochem Cell Biol 1983;61:615-624.
4. Wilson T, Liggins GC, Aimer GP, Watkins EJ: The effect of progesterone on the release of arachidonic acid from human endometrial cells stimulated by histamine. Prostaglandins 1986;31:343-360.
5. Junqueira LC, Zugaib M, Montes GS, Toledo OM, Krisztan RM, Shigihara KM: Morphologic and histochemical evidence for the occurrence of collagenolysis and for the role of neutrophilic polymorphonuclear leukocytes during cervical dilation. Am J Obstet Gynecol 1980;138:273-281.
6. Osmers RG, Adelmann Grill BC, Rath W, Stuhlsatz HW, Tschesche H, Kuhn W: Biochemical events in cervical ripening dilatation during pregnancy and parturition. J Obstet Gynaecol 1995;21: 185-194.
7. McLaren J, Malak TM, Bell SC: Structural characteristics of term human fetal membranes prior to labour: Identification of an area of altered morphology overlying the cervix. Hum Reprod 1999;14: 237-241.
8. McLaren J, Taylor DJ, Bell SC: Increased incidence of apoptosis in non-labour-affected cytotrophoblast cells in term fetal membranes overlying the cervix. Hum Reprod 1999;14:2895-2900.
9. McLaren J, Taylor DJ, Bell SC: Increased concentration of pro-matrix metalloproteinase 9 in term fetal membranes overlying the cervix before labor: Implications for membrane remodeling and rupture. Am J Obstet Gynecol 2000;182:409-416.
10. Turnbull A: The Fetus and Birth. London, Elsevier, 1977.
11. Skinner KA, Challis JR: Changes in the synthesis and metabolism of prostaglandins by human fetal membranes and decidua at labor. Am J Obstet Gynecol 1985;151:519-523.
12. Crankshaw DJ, Dyal R: Effects of some naturally occurring prostanoids and some cyclooxygenase inhibitors on the contractility of the human lower uterine segment in vitro. Can J Physiol Pharmacol 1994;72:870-874.
13. Liggins G: Initiation of labour. Biol Neonate 1989;55:366-375.
14. Garfield RE, Hertzberg EL: Cell-to-cell coupling in the myometrium: Emil Bozler's prediction. Prog Clin Biol Res 1990;327:673-681.
15. Bennett PR, Slater D, Sullivan M, Elder MG, Moore GE: Changes in amniotic arachidonic acid metabolism associated with increased cyclo-oxygenase gene expression. Br J Obstet Gynaecol 1993; 100:1037-1042.
16. Bennett PR, Elder MG, Myatt L: The effects of lipoxygenase metabolites of arachidonic acid on human myometrial contractility. Prostaglandins 1987;33:837-844.
17. Walsh SW: 5-Hydroxyeicosatetraenoic acid, leukotriene C4 and prostaglandin F2α in amniotic fluid before and during term and preterm labor. Am J Obstet Gynecol 1989;161:1352.
18. Skannal DG, Brockman DE, Eis AL, Xue S, Siddiqi TA, Myatt L: Changes in activity of cytosolic phospholipase A2 in human amnion at parturition. Am J Obstet Gynecol 1997;177:179-184.
19. Munns MJ, Farrugia W, King RG, Rice GE: Secretory type II PLA2 immunoreactivity and PLA2 enzymatic activity in human gestational tissues before, during and after spontaneous-onset labour at term. Placenta 1999;20:21-26.
20. Bennett PR, Rose MP, Myatt L, Elder MG: Preterm labor: Stimulation of arachidonic acid metabolism in human amnion cells by bacterial products. Am J Obstet Gynecol 1987;156:649-655.
21. Slater D, Dennes W, Sawdy R, Allport V, Bennett P: Expression of cyclo-oxygenase types-1 and -2 in human fetal membranes throughout pregnancy. J Mol Endocrinol 1999;22:125-130.
22. Brown NL, Slater DM, Alvi SA, Elder MG, Sullivan MH, Bennett PR: Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein in human fetal membranes throughout pregnancy and at term. Mol Hum Reprod 1999;5:668-674.
23. Marshall P, Kulmacz R, Lands W: Constraints on prostaglandin synthesis in tissues. J Biol Chem 1979;262:3510-3517.
24. Hla T, Neilson K: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992;89:7384-7388.
25. O'Banion MK, Sadowski HB, Winn V, Young DA: A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991;266:23261-23267.
26. Needleman P, Isakson PC: The discovery and function of COX-2. J Rheumatol 1997;24(suppl 49):6-8.
27. Rice GE, Payne MJ, Wong MH, Thorburn GD: Immunoreactive prostaglandin G/H synthase content increases in ovine cotyledons during late gestation. Placenta 1992;13:429-437.
28. Wimsatt J, Nathanielsz PW, Sirois J: Induction of prostaglandin endoperoxide synthase isoform-2 in ovine cotyledonary tissues during late gestation. Endocrinology 1993;133:1068-1073.
29. Rice GE, Freed KA, Aitken MA, Jacobs RA: Gestational- and labour-associated changes in the relative abundance of prostaglandin G/H synthase-1 and -2 mRNA in ovine placenta. J Mol Endocrinol 1995;14:237-245.
30. Slater DM, Berger LC, Newton R, Moore GE, Bennett PR: Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term. Am J Obstet Gynecol 1995;172:77-82.
31. Slater D, Berger L, Newton R, Moore G, Bennett P: The relative abundance of type 1 to type 2 cyclo-oxygenase mRNA in human amnion at term. Biochem Biophys Res Commun 1994;198:304-308.
32. Sawdy RJ, Slater DM, Dennes WJ. Sullivan MH, Bennett PR: The roles of the cyclo-oxygenases types one and two in prostaglandin synthesis in human fetal membranes at term. Placenta 2000;21: 54-57.
33. Sadovsky Y, Nelson DM, Muglia LJ, Gross GA, Harris KC, Koki A, Masferrer JL, Olson LM: Effective diminution of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2. Am J Obstet Gynecol 2000;182:370-376.
34. Gross G, Imamura T, Vogt SK, Wozniak DF, Nelson DM, Sadovsky Y, Muglia LJ: Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse. Am J Physiol Regul Integr Comp Physiol 2000;278:R1415-R1423.
35. Cheung PY, Walton JC, Tai HH, Riley SC, Challis JR: Immunocytochemical distribution and localization of 15-hydroxyprostaglandin dehydrogenase in human fetal membranes, decidua, and placenta. Am J Obstet Gynecol 1990;163:1445-1449.
36. Sangha RK, Walton JC, Ensor CM, Tai HH, Challis JR: Immunohistochemical localization, messenger ribonucleic acid abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labor. J Clin Endocrinol Metab 1994;78:982-989.
37. Van Meir CA, Ramirez MM, Matthews SG, Calder AA, Keirse MJ, Challis JR: Chorionic prostaglandin catabolism is decreased in the lower uterine segment with term labour. Placenta 1997;18: 109-114.
38. Van Meir CA, Sangha RK, Walton JC, Matthews SG, Keirse MJ, Challis JR: Immunoreactive 15-hydroxyprostaglandin dehydrogenase (PGDH) is reduced in fetal membranes from patients at preterm delivery in the presence of infection. Placenta 1996;17:291-297.
39. Colditz IG: Effect of exogenous prostaglandin E2 and actinomycin D on plasma leakage induced by neutrophil-activating peptide-1/interleukin-8. Immunol Cell Biol 1990;68:397-403.
40. Rampart M, Jose PJ, Williams TJ: Rabbit leukocytes activated by C5a des Arg and N-formylmethionyl-leucyl-phenylalanine promote endothelial prostacyclin production. Evidence for a role of hydrogen peroxide. Eicosanoids 1989;2:109-115.
41. Kelly RW: Inflammatory mediators and parturition. Rev Reprod 1996;1:89-96.
42. Elliott CL, Kelly RW, Critchley HO, Riley SC, Calder AA: Regulation of interleukin 8 production in the term human placenta during labor and by antigestagens. Am J Obstet Gynecol 1998;179: 215-220.
43. Elliott CL, Brennand JE, Calder AA: The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstet Gynecol 1998;92(5):804-809.
44. Chwalisz K, Garfield RE: Antiprogestins in the induction of labor. Ann NY Acad Sci 1994;734: 387-413.
45. Miller C, Zhang M, He Y, Zhao J, Pelletier JP, Martel-Pelletier J, Di Battista JA: Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins. J Cell Biochem 1998;69: 392-413.
46. Wang Z, Tai HH: Cyclic AMP response element mediates dexamethasone induced suppression of prostaglandin H synthase-2 gene expression in human amnion derived WISH cells. Prostaglandins Leukot Essent Fatty Acids 1999;60:243-248.
47. Chen G, Wood EG, Wang SH, Warner TD: Expression of cyclooxygenase-2 in rat vascular smooth muscle cells is unrelated to nuclear factor-kappaB activation. Life Sci 1999;64:1231-1242.
48. Sirois J, Richards JS: Transcriptional regulation of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Evidence for the role of a cis-acting C/EBP beta promoter element. J Biol Chem 1993;268:21931-21938.
49. Kim Y, Fischer SM: Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J Biol Chem 1998;273:27686-27694.
50. Newton R, Kuitert LM, Bergmann M, Adcock IM, Barnes PJ: Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun 1997;237:28-32.
51. Belt AR, Baldassare JJ, Molnar M, Romero R, Hertelendy F: The nuclear transcription factor NF-kappaB mediates interleukin-1beta- induced expression of cyclooxygenase-2 in human myometrial cells. Am J Obstet Gynecol 1999;181:359-366
52. Lukiw WJ, Bazan NG: Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex. J Neurosci Res 1998;53:583-592.
53. Crofford LJ, Tan B, McCarthy CJ, Hla T: Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum 1997; 40:226-236.
54. Mukaida N, Shiroo M, Matsushima K: Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1989;143:1366-1371.
55. Harant H, Andrew PJ, Reddy GS, Foglar E, Lindley IJ: 1alpha,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappaB-mediated interleukin-8 gene expression. Eur J Biochem 1997;250:63-71.
56. Baldwin AS Jr: The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 1996;14:649-683.
57. Allport VC, Slater DM, Newton R, Bennett PR: NF-kappaB and AP-1 are required for cyclooxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol Hum Reprod 2000;6:561-565.
58. Potter S, Mitchell MD, Hansen WR, Marvin KW: NF-IL6 and CRE elements principally account for both basal and interleukin-1beta-induced transcriptional activity of the proximal 528 bp of the PGHS-2 promoter in amnion-derived AV3 cells: Evidence for involvement of C/EBPbeta. Mol Hum Reprod 2000;6:771-778.
59. Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C: Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997;100:2961-2969.
60. Dejardin E, Deregowski V, Chapelier M, Jacobs N, Gielen J, Merville MP, Bours V: Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells. Oncogene 1999;18: 2567-2577.
61. Elsharkawy AM, Wright MC, Hay RT, Arthur MJ, Hughes T, Bahr MJ, Degitz K, Mann DA: Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins. Hepatology 1999;30:761-769.
62. Lye S: The initiation and inhibition of labour - Toward a molecular understanding. Semin Reprod Endocrinol 1994;12:284-294.
63. Chwalisz K, Benson M, Scholz P, Daum J, Beier HM, Hegele Hartung C: Cervical ripening with the cytokines interleukin 8, interleukin 1 beta and tumour necrosis factor alpha in guinea-pigs. Hum Reprod 1994;9:2173-2181.
64. Mitchell BF, Wong S: Changes in 17 beta,20 alpha-hydroxysteroid dehydrogenase activity supporting an increase in the estrogen/progesterone ratio of human fetal membranes at parturition. Am J Obstet Gynecol 1993;168:1377-1385.
65. Karalis K, Goodwin G, Majzoub JA: Cortisol blockade of progesterone: A possible molecular mechanism involved in the initiation of human labor. Nat Med 1996;2:556-560.
66. Chaim W, Mazor M: The relationship between hormones and human parturition. Arch Gynecol Obstet 1998;262:43-51.
67. Kalkhoven E, Wissink S, van der Saag PT, van der Burg B: Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor. J Biol Chem 1996;271:6217-6224.
68. De Bosscher K, Schmitz ML, Vanden Berghe W, Plaisance S, Fiers W, Haegeman G: Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci USA 1997;94:13504-13509.
69. Dumont A, Hehner SP, Schmitz ML, Gustafsson JA, Liden J, Okret S, van der Saag PT: Cross-talk between steroids and NF-kappa B: What language? Trends Biochem Sci 1998;23:233-235.
70. Sheppard KA, Rose DW, Haque ZK, Kurokawa R, McInerney E, Westin S, Thanos D, Rosenfeld MG, Glass CK, Collins T: Transcriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol 1999;19:6367-6378.